Get the Stockscreener App
2.905
14.81%
-0.505
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Zynex Inc stock is traded at $2.905, with a volume of 1.32M.
It is down -14.81% in the last 24 hours and down -61.62% over the past month.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
See More
Previous Close:
$3.41
Open:
$3.38
24h Volume:
1.32M
Relative Volume:
8.74
Market Cap:
$92.71M
Revenue:
$193.67M
Net Income/Loss:
$4.82M
P/E Ratio:
20.71
EPS:
0.1403
Net Cash Flow:
$15.53M
1W Performance:
-60.04%
1M Performance:
-61.62%
6M Performance:
-64.36%
1Y Performance:
-77.11%
1-Day Range:
$2.77
$3.50
1-Week Range:
$2.77
$7.43
52-Week Range:
$2.77
$13.19
Zynex Inc Stock (ZYXI) Company Profile
Name
Zynex Inc
Sector
Industry
Phone
(800)-495-6670
Address
9655 MAROON CIRCLE, ENGLEWOOD, CO
Compare ZYXI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 9.30 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.1898 | 400.55M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.73 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.68 | 115.41M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
5.15 | 66.99M | 0 | 0 | 0 | 0.00 |
|
USVM
USAA MSCI USA Small Cap Value M
|
76.56 | 0 | 0 | 0 | 0 | 0.00 |
Zynex Inc Stock (ZYXI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-16-23 | Initiated | RBC Capital Mkts | Outperform |
| Jan-06-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-28-22 | Reiterated | B. Riley Securities | Buy |
| Jul-16-21 | Upgrade | B. Riley Securities | Neutral → Buy |
| Mar-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Feb-26-21 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-28-21 | Downgrade | Northland Capital | Outperform → Market Perform |
| Sep-14-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-09-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-29-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jul-20-20 | Initiated | Piper Sandler | Overweight |
| Jul-13-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jul-10-20 | Reiterated | H.C. Wainwright | Neutral |
| Jun-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-19-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-01-20 | Initiated | Northland Capital | Outperform |
| Sep-23-19 | Initiated | H.C. Wainwright | Buy |
View All
Zynex Inc Stock (ZYXI) Latest News
Zynex (NASDAQ:ZYXI) Rating Lowered to Neutral at LADENBURG THALM/SH SH - Defense World
Zynex Inc. (ZYXI) Reports Q4 Loss, Misses Revenue Estimates - MSN
Zynex, Inc. (NASDAQ:ZYXI) CEO Thomas Sandgaard, the company's largest shareholder sees 53% reduction in holdings value - Simply Wall St
Zynex Inc. Confronts Legal Challenges: Potential Litigation and Its Impact on Business Stability - TipRanks
Zynex Inc’s Earnings Call: Growth Amidst Challenges - TipRanks
Securities Fraud Investigation Into Zynex, Inc. (ZYXI) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
H.C. Wainwright cuts Zynex stock price target to $15, maintains Buy - Investing.com Australia
Zynex Buy Rating Maintained Amid Revenue Challenges and Growth Potential - TipRanks
INVESTOR ALERT: Investigation of Zynex, Inc. (ZYXI) Announced by Holzer & Holzer, LLC - GlobeNewswire
Zynex's Sell-Off Creates A Speculative Buying Opportunity (NASDAQ:ZYXI) - Seeking Alpha
Zynex stock drops as RBC downgrades on Q4 miss (ZYXI:NASDAQ) - Seeking Alpha
Zynex drops as RBC Capital Markets downgrades after Q4 miss - MSN
Zynex downgraded by RBC Capital Mkts with a new price target - Quantisnow
Zynex downgraded by Ladenburg Thalmann - Quantisnow
Zynex, Inc. (NASDAQ:ZYXI) Q4 2024 Earnings Call Transcript - Insider Monkey
H.C. Wainwright cuts Zynex stock price target to $15, maintains Buy By Investing.com - Investing.com South Africa
Top Premarket Decliners -March 12, 2025 at 07:47 am EDT - Marketscreener.com
RBC Downgrades Zynex to Sector Perform From Outperform, Cuts Price Target to $5.50 from $11 - Marketscreener.com
Zynex downgraded to Sector Perform from Outperform at RBC Capital - TipRanks
Zynex stock hits 52-week low at $6.99 amid market challenges - Investing.com India
RBC Capital cuts Zynex stock rating amid operational concerns By Investing.com - Investing.com South Africa
Zynex Inc (ZYXI) Q4 2024 Earnings Call Highlights: Navigating Challenges and Opportunities - Yahoo Finance
Zynex Inc (ZYXI) Q4 2024 Earnings Call Highlights: Navigating Ch - GuruFocus.com
Zynex Inc. Reports 2024 Financial Results and Strategic Adjustments - TipRanks
Zynex Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve
Earnings call transcript: Zynex Q4 2024 misses EPS, stock drops 20% By Investing.com - Investing.com South Africa
Earnings call transcript: Zynex Q4 2024 misses EPS, stock drops 20% - Investing.com UK
Zynex Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ZYNEX Earnings Results: $ZYXI Reports Quarterly Earnings - Nasdaq
ZYNEX INC SEC 10-K Report - TradingView
Zynex delivers solid growth with rising orders and expanding product innovation - Proactive Investors USA
Zynex shares tumble on earnings miss, weak guidance By Investing.com - Investing.com South Africa
Zynex reports Q4 EPS (2c), consensus 9c - TipRanks
Zynex Slashes 15% of Workforce After Tricare Payment Suspension Hits Revenue - StockTitan
Insider Sale: CFO Daniel Moorhead Sells 10,000 Shares of Zynex I - GuruFocus.com
ZYNEX Earnings Preview: Recent $ZYXI Insider Trading, Hedge Fund Activity, and More - Nasdaq
Zynex Inc expected to post earnings of 9 cents a shareEarnings Preview - TradingView
Zynex, Inc. to Host Earnings Call - ACCESS Newswire
Zynex (ZYXI) Projected to Post Earnings on Tuesday - Defense World
Zynex CFO Daniel Moorhead sells $71,500 in company stock By Investing.com - Investing.com Australia
Zynex CFO Daniel Moorhead sells $71,500 in company stock - Investing.com
Zynex stock touches 52-week low at $7.12 amid market challenges - Investing.com Australia
Is There Now An Opportunity In Zynex, Inc. (NASDAQ:ZYXI)? - Yahoo Finance
Zynex Sets Fourth Quarter and Year End 2024 Earnings Call - The Malaysian Reserve
Zynex stock touches 52-week low at $7.12 amid market challenges By Investing.com - Investing.com South Africa
Zynex Sets Fourth Quarter And Year End 2024 Earnings Call - MENAFN.COM
Mark Your Calendar: Zynex Medical Technology Earnings Report Coming March 11 - StockTitan
(ZYXI) Trading Advice - Stock Traders Daily
Zynex COO on pain management innovations and growth plans – ICYMI - Proactive Investors UK
Zynex COO highlights strong reimbursement strategy and growth in non-opioid pain management - Proactive Investors USA
Zynex Inc to Host Earnings Call - ACCESS Newswire
Zynex Inc Stock (ZYXI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):